Insights

Growth Potential With Amgen's announced plan to acquire Dark Blue Therapeutics for up to $840 million, there is a significant indication of potential expansion, funding opportunities, and future partnership prospects within the company.

Innovative Focus Dark Blue's emphasis on precision cancer medicines utilizing groundbreaking biological insights suggests a need for advanced technological solutions, data analytics, and R&D support to accelerate drug development processes.

Market Positioning As a relatively small biotech firm with a pioneering approach, Dark Blue may benefit from sales collaborations related to lab automation, clinical trial management, or specialty pharma services to support its innovative pipeline.

Financial Opportunities Given the company's current revenue range and recent acquisition interest, there is potential to offer funding, partnership, or service solutions that align with their growth trajectory and upcoming clinical milestones.

Technological Needs Dark Blue's technology stack and focus on cutting-edge research imply a demand for advanced biotechnology tools, cloud services, and data security platforms to support scalable, compliant, and efficient drug discovery workflows.

Dark Blue Therapeutics Tech Stack

Dark Blue Therapeutics uses 8 technology products and services including cdnjs, Open Graph, LottieFiles, and more. Explore Dark Blue Therapeutics's tech stack below.

cdnjs

Content Delivery Network

Open Graph

Content Management System

LottieFiles

Design

Microsoft 365

Cloudflare Bot Management

Security

Google Tag Manager

Tag Management

Google Analytics

Web Analytics

GoDaddy

Web Hosting

Dark Blue Therapeutics Email Formats	Example	Percentage
FLast@darkbluetx.com	JDoe@darkbluetx.com	92%
First.Last@darkbluetx.com	John.Doe@darkbluetx.com	8%

Dark Blue Therapeutics Email Formats

Example

Percentage

FLast@darkbluetx.com

JDoe@darkbluetx.com

92%

First.Last@darkbluetx.com

John.Doe@darkbluetx.com

Frequently Asked Questions

Where is Dark Blue Therapeutics's headquarters located?

Dark Blue Therapeutics's main headquarters is located at Robert Robinson Avenue Oxford, England United Kingdom. The company has employees across 1 continents, including Europe.

What is Dark Blue Therapeutics's official website and social media links?

Dark Blue Therapeutics's official website is darkbluetx.com and has social profiles on LinkedIn.

What is Dark Blue Therapeutics's SIC code NAICS code?

Dark Blue Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dark Blue Therapeutics have currently?

As of June 2026, Dark Blue Therapeutics has approximately 14 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: A. M.Chief Scientific Officer: J. P.Chief Financial Officer: E. S.. Explore Dark Blue Therapeutics's employee directory with LeadIQ.

What industry does Dark Blue Therapeutics belong to?

Dark Blue Therapeutics operates in the Biotechnology Research industry.

What technology does Dark Blue Therapeutics use?

Dark Blue Therapeutics's tech stack includes cdnjsOpen GraphLottieFilesMicrosoft 365Cloudflare Bot ManagementGoogle Tag ManagerGoogle AnalyticsGoDaddy.

What is Dark Blue Therapeutics's email format?

Dark Blue Therapeutics's email format typically follows the pattern of FLast@darkbluetx.com. Find more Dark Blue Therapeutics email formats with LeadIQ.

When was Dark Blue Therapeutics founded?

Dark Blue Therapeutics was founded in 2020.

Dark Blue Therapeutics

Q: What is Dark Blue Therapeutics's official website and social media links?

Dark Blue Therapeutics's official website is darkbluetx.com. Dark Blue Therapeutics has social profiles on LinkedIn.

Q: How many employees does Dark Blue Therapeutics have currently?

Dark Blue Therapeutics has approximately 14 employees.

Q: What technology does Dark Blue Therapeutics use?

Dark Blue Therapeutics's tech stack includes Google Tag Manager, Cloudflare Bot Management, Apple iCloud Mail, Piwik PRO Core, cdnjs.

Q: What is Dark Blue Therapeutics's NAICS code?

Dark Blue Therapeutics's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies.

Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK. We have assembled a highly experienced team, whose expertise spans the breadth of drug development from discovery to approval. This expertise has been gained over many years in the industry and draws from biotech, large pharmaceutical companies and investment management. 

Dark Blue leverages ground-breaking cancer biology insights, from Oxford University, to discover and develop innovative precision medicines that exploit novel vulnerabilities and dependencies.  With this deep, proprietary understanding of target biology we match our precision medicines to molecularly defined patient populations to develop transformative, durable drugs that address critical unmet patient needs, delivering medicines that transform the outcomes for cancer patients. We work across a variety of biological mechanisms to identify and pursue only cancer targets that have the highest transformative potential.

Insights

Similar companies to Dark Blue Therapeutics

Forma Therapeutics (Now Novo Nordisk)

Volastra Therapeutics